Insmed reported $74.55M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
BioMarin Pharmaceutical USD 913.67M 120.52M Jun/2026
Cytokinetics USD 20.51M 4.2M Jun/2026
DBV Technologies USD 39.5M 1.44M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
Heron Therapeutics USD 11.64M 2.67M Jun/2026
Insmed USD 74.55M 1.18M Jun/2026
Novartis USD 4.32B 134M Mar/2026
Regeneron Pharmaceuticals USD 1.16B 132.2M Jun/2026
Sarepta Therapeutics USD 50.98M 19.39M Jun/2026
Ultragenyx Pharmaceutical USD 39M 3M Jun/2026
Vertex Pharmaceuticals USD 3.61B 135M Jun/2026